Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary...

Area of Science:

• Cardiology
• Biomarkers
• Interventional Cardiology

Background:

• ST-segment elevation myocardial infarction (STEMI) with elevated troponin T (>0.1 microg/L) on admission indicates a poorer prognosis.
• Early reperfusion strategies in STEMI require further evaluation of underlying factors contributing to adverse outcomes.

Purpose of the Study:

• To investigate the predictive value of cardiac troponin T (cTnT) for clinical outcomes, epicardial blood flow, and myocardial reperfusion.
• To understand the association between admission cTnT levels and patient outcomes after primary percutaneous intervention.

Main Methods:

• 140 patients admitted within 12 hours of STEMI symptom onset were stratified by admission cTnT levels.
• Epicardial reperfusion was assessed using the TIMI score.
• Myocardial reperfusion was evaluated by measuring relative increases in myoglobin, cTnT, and creatine kinase-MB (CK-MB) 60 minutes post-recanalization.

Main Results:

• Admission cTnT positivity (45.7%) was linked to longer admission times, higher 30-day and 9-month mortality rates.
• cTnT independently predicted a 3.2-fold increased risk of incomplete epicardial reperfusion.
• Elevated cTnT correlated with more severely impaired myocardial perfusion despite normal epicardial flow, evidenced by lower biomarker ratios post-intervention.

Conclusions:

• Cardiac troponin T is a significant predictor of poorer clinical outcomes, reduced postprocedural TIMI 3 flow, and compromised myocardial perfusion.
• Patients with elevated cTnT may benefit from more aggressive adjunctive therapies during percutaneous coronary intervention.
• Further research is needed to evaluate the role of microvascular dysfunction and targeted therapies for myocardial perfusion.